FDA Approves Hologic's Makena

Hologic, Inc. HOLX announced today the U.S. Food and Drug Administration (FDA) has approved Hologic's pharmaceutical named Makena, formerly known as Gestiva. Per the terms of an asset purchase agreement (the Agreement) between Hologic and KV Pharmaceutical Company, Hologic will transfer the Company's Makena assets to KV upon the satisfaction of certain conditions, including receipt of a $12.5 million cash payment from KV. Transfer is expected to be completed by February 11, 2011.